Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000-Reference-Cited by-同舟云学术

Results of second salvage therapy in 673 adults with acute myelogenous leukemia treated at a single institution since 2000

Published:2018-04-12 Issue:12 Volume:124 Page:2534-2540
ISSN:0008-543X
Container-title:Cancer
language:en
Short-container-title:Cancer

Author:

Kantarjian Hagop M.¹^ORCID,DiNardo Courtney D.¹^ORCID,Nogueras-Gonzalez Graciela M.²,Kadia Tapan M.¹^ORCID,Jabbour Elias¹^ORCID,Bueso-Ramos Carlos E.³,O'Brien Susan M.⁴^ORCID,Konopleva Marina¹,Jain Nitin B.¹,Daver Naval G.¹^ORCID,Shpall Elizabeth J.⁵,Champlin Richard E.⁵,Simkins Aron⁶,Garcia-Manero Guillermo¹,Keating Michael J.¹,Huang Xuelin²,Cortes Jorge E.¹,Pierce Sherry A.¹,Ravandi Farhad¹,Freireich Emil J.¹

Affiliation:

1. Department of Leukemia; The University of Texas MD Anderson Cancer Center; Houston Texas

2. Department of Biostatistics; The University of Texas MD Anderson Cancer Center; Houston Texas

3. Department of Hematopathology; The University of Texas MD Anderson Cancer Center; Houston Texas

4. Chao Family Comprehensive Cancer Center; University of California at Irvine; Irvine California

5. Department of Cellular Therapy and Stem Cell Transplantation; The University of Texas MD Anderson Cancer Center; Houston Texas

6. Department of Internal Medicine; University of Texas Health Science Center; Houston Texas

Funder

Charif Souki Cancer Research

University of Texas MD Anderson Cancer Center

Programs of Research Excellence (SPORE)

Astellas Pharma US

Daiichi Sanky

Novartis

Jazz Pharmaceuticals

Pfizer

ImmunoGen

Celgene

AbbVie

Genetech

Cellectis

Stemline Therapeutics

Eli Lilly and Company

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference16 articles.

1. Acute myeloid leukemia-major progress over 4 decades and glimpses into our future;Kantarjian;Am J Hematol.,2016

2. Acute myeloid leukemia;Dohner;N Engl J Med,2015

3. Prognostic index for adult patients with acute myeloid leukemia in first relapse;Breens;J Clin Oncol,2005

4. Prognostic factors and outcomes of adult patients with acute myeloid leukemia after first relapse;Kurosawa;Haematologica,2010

5. Clofarabine plus cytarabine compared with cytarabine alone in older patients with relapsed or refractory acute myelogenous leukemia: results from the CLASSIC I Trial;Faderl;J Clin Oncol,2012

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of mitoxantrone, etoposide, and cytarabine for treatment of relapsed or refractory acute myeloid leukemia;Leukemia Research;2024-04

2. Results of a phase I trial with Haploidentical mbIL‐21 ex vivo expanded NK cells for patients with multiply relapsed and refractory AML;American Journal of Hematology;2024-03-05

3. Identification and validation of pyroptosis patterns in AML via comprehensive bioinformatics analysis;2023-11-15

4. Use of tamibarotene, a potent and selective RARα agonist, in combination with azacitidine in patients with relapsed and refractory AML with RARA gene overexpression;Leukemia & Lymphoma;2023-08-12

5. The Role of BCL-2/MCL-1 Targeting in Acute Myeloid Leukemia;Pathogenesis and Treatment of Leukemia;2023